Transdermal Drug Delivery System Market Analysis

  • Report ID: 6880
  • Published Date: Dec 27, 2024
  • Report Format: PDF, PPT

Transdermal Drug Delivery System Market Analysis

Technology (Electroporation, Radio Frequency, Iontophoresis, Microporation, Thermal, Mechanical arrays, Ultrasound)

The iontophoresis segment is set to hold more than 22.2% transdermal drug delivery system market share by 2037. This technology enhances drug penetration through the skin using a mild electrical current, facilitating the delivery of both large and small molecules and expanding its applications. A December 2022 study published in the National Library of Medicine demonstrated a 97% swear reduction in four weeks, highlighting its effectiveness. Iotophoresis is non-invasive, offers precise drug release control, and improves treatment outcomes, driving its adoption in treatment outcomes, driving its adoption in therapeutic areas such as pain management and local anesthesia. Thus, propelling the market.

Application (CNS, Pain Management, Cardiovascular, Hormone, Immunological, Metabolic, Gastrointestinal, Infection, Cancer)

Based on application, the pain management segment is slated to hold dominant market share over the forecast period for the transdermal drug delivery system market. The segment’s growth is driven by increasing demand for non-invasive, effective solutions for chronic pain relief. Transdermal patches offer sustained, controlled drug release, ensuring consistent pain management without the need for oral medication or injections. A January 2024 study by Talnia et al. found that   72% of patients experienced great pain relief from analgesic patches.  This convenience, coupled with reduced side effects and improved patient compliance, makes transdermal systems a preferred choice for managing conditions like arthritis, neuropathy, and musculoskeletal pain.

Our in-depth analysis of the global market includes the following segments:

Technology

  • Electroporation
  • Radio Frequency
  • Iontophoresis
  •  Microporation
  •  Thermal
  • Mechanical arrays
  •  Ultrasound
  • Others

Application

  • CNS
  • Pain Management
  • Cardiovascular
  • Hormone
  • Immunological
  • Metabolic
  • Gastrointestinal
  • Infection
  • Cancer
  • Others
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6880
  • Published Date: Dec 27, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the transdermal drug delivery system market was over USD 74.6 billion.

The market size for the transdermal drug delivery system market is projected to reach USD 296.9 billion by the end of 2037 expanding at a CAGR of 12.2% during the forecast period i.e., between 2025-2037.

The major players in the market are Johnson & Johnson, Mylan Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, 3M Company, and others.

In terms of technology, the iontophoresis segment is anticipated to garner the largest market share by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 47.6 % by the end of 2037 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample